作为的补充治疗方法的黑素:系统性审查和元分析
Zhifan Liu1, Jie Zhu2, Ziyi Shen1
1Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Institute of neurological diseases, North Sichuan Medical College, Nanchong 637000, Sichuan, PR China.
Seizure
|February 28, 2024
概括
作为的补充治疗方法,黑素显示出减轻发作严重程度和改善睡眠延迟的前景. 需要进一步的研究来证实其在管理中的长期疗效和安全性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种普遍的脑部疾病,影响着全球数以百万计的人.
- 目前的药物治疗对大约三分之一的患者是无效的.
- 黑素正在研究其潜在的抗性质和安全性.
研究的目的:
- 系统地审查黑激素作为的辅助疗法的疗效和安全性.
- 评估黑激素对患者睡眠和发作参数的影响.
主要方法:
- 在Web of Science,Cochrane图书馆和PubMed进行了系统的文献搜索,截至2023年6月.
- 十个随机对照试验 (RCT) 被纳入了元分析.
- 使用RevMan 5.4软件计算了相对风险 (RR) 和95%的置信区间 (CI).
主要成果:
- 添加黑激素显著改善了睡眠延迟时间 (RR:0.56;95%CI:0.10-1.02;P = 0.02).
- 与安慰剂相比,黑素还可以降低发作的严重程度 (RR:0.33;95%CI:0.04-0.62;P = 0.03).
- 副作用是最小的,并且仅在一个试验中报告.
结论:
- 补充黑激素疗法在改善睡眠延迟和减少发作严重程度方面显示出潜在的益处.
- 局限性包括对睡眠质量,和安全性的不一致评估,以及缺乏长期数据.
- 为了建立最终的疗效和安全概况,需要进行更多具有扩展后续的高质量的RCT.
相关概念视频
Management of Insomnia
247
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
247
Antiepileptic Drugs: Glutamate Antagonists
345
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
345
Sedatives and Hypnotics Drugs: Miscellaneous Agents
172
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
172
Narcolepsy
102
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
102
Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399


